Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2013
06/12/2013CN102260256B Diaryl pyrazolo [3,4-b] pyridine heterocyclic compound as well as preparation method and drug application
06/12/2013CN102186851B Triazolopyridine compounds as pim kinase inhibitors
06/12/2013CN102093353B 7-substituted aza-indazoles, compositions containing same, production method and use thereof
06/12/2013CN101874019B Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
06/12/2013CN101445422B Organic electroluminescent material and application thereof
06/11/2013US8461333 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
06/11/2013US8461328 Tricyclic heterocyclic compounds, compositions and methods of use thereof
06/11/2013US8461181 Fused heterocyclic compound and use thereof
06/11/2013US8461178 Naphthyridine derivatives and the use thereof as kinase inhibitors
06/11/2013US8461175 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
06/11/2013CA2683453C Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-.beta.]indoles, methods for the production and use thereof
06/06/2013WO2013081783A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
06/06/2013WO2013081400A2 Novel benzamide derivative and use thereof
06/06/2013WO2013081094A1 Imidazo[1,2-a]pyridine derivative and use thereof for medical purposes
06/06/2013WO2013080222A1 Substituted pyridine derivatives as fabi inhibitors
06/06/2013WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives
06/06/2013WO2013079217A1 Display
06/06/2013WO2013078544A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
06/06/2013WO2013078523A1 Heterocyclic n-glycinyl-n-acyl hydrazone compounds, synthesis method, pharmaceutical compositions and treatment method
06/06/2013WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
06/06/2013US20130144062 Heteroaryl carboxamides
06/06/2013US20130143915 Triazolopyridines as tyk2 inhibitors
06/06/2013US20130143914 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract
06/06/2013US20130143907 Pyrazoloquinoline derivatives
06/06/2013US20130143900 Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
06/06/2013US20130143899 Compounds and compositions as protein kinase inhibitors
06/06/2013US20130143895 Bicyclic compounds and their uses as dual c-src / jak inhibitors
06/06/2013US20130143893 Piperazine derivatives and methods of use
06/06/2013US20130143880 Positive allosteric modulators of mglur2
06/06/2013US20130143879 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
06/06/2013US20130143878 Substituted dibenzonaphthyridines, pharmaceutical uses thereof and processes therfor
06/06/2013US20130143863 New bicyclic dihydroisoquinoline-1-one derivatives
06/06/2013US20130143841 Benzoheterocyclic anti-bacterial agents
06/06/2013DE112011102597T5 Triazolderivat, heterocyclische Verbindung, lichtemittierendes Element, lichtemittierende Vorrichtung, elektronische Vorrichtung und Beleuchtungsvorrichtung Triazole derivative, heterocyclic compound, a light emitting element, light emitting device, electronic device and illumination device
06/06/2013CA2857193A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
06/06/2013CA2855001A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
06/06/2013CA2850700A1 New bicyclic dihydroisoquinoline-1-one derivatives
06/05/2013EP2599780A1 Phenanthroline compound, electron transport material obtained from said compound, and organic thin-film photovoltaic cell comprising said compound
06/05/2013EP2599386A1 2-aminopyrimidine modulators of the histamine h4 receptor
06/05/2013EP2598503A1 Cis-tetrahydrospiro(cyclohexane-1,1'-pyrido[3,4-b]indol)-4-amine derivatives
06/05/2013EP2598498A1 Hetero-bicyclic derivatives as hcv inhibitors
06/05/2013EP2598486A1 Bicyclic acetyl-coa carboxylase inhibitors
06/05/2013EP2598483A1 Ampk-activating heterocyclic compounds and methods for using the same
06/05/2013EP2598481A1 Sulfonamide compounds useful as cyp17 inhibitors
06/05/2013CN103140490A Azaindazole compounds
06/05/2013CN103140489A Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract
06/05/2013CN103140488A Compounds and compositions for mitigating tissue damage and lethality
06/05/2013CN103140480A Heterocyclic compounds, their preparation and their therapeutic application
06/05/2013CN103130865A Sophocarpidine, oxymatrine glycyrrhetinic acid double salt, and preparation method and use thereof
06/05/2013CN103130806A Phenanthroindo(quio)lizidine alkaloid derivative, and preparation, anti-TMV activity, anti-HIV activity and anti-tumor activity thereof
06/05/2013CN103130804A N,N'-dialkyl-14H-benzo[4,5]isoquinolino[2,1-a]perimidine-14-one-3,4,10,11-diimide compound and preparation method and application thereof
06/05/2013CN103130803A Oxidized iso-aporphine alkaloid derivative, synthetic method and application
06/05/2013CN103130802A Tetrahydro-gamma-carboline derivative synthesis method
06/05/2013CN103130801A Substituted beta-carboline compound and preparation method thereof
06/05/2013CN103130800A 1,3,6,9-substitution beta-carboline compound and preparation method thereof
06/05/2013CN103130799A Preparing method of 2-hydroxy pyridino-6,7,8,9-tetrahydro-5H- pyridine[2,3-d] azepine derivative
06/05/2013CN103130792A 2-aminothiazoles compound
06/05/2013CN103130723A Poly (aenosine diphosphate glucose pyrophospheralase (ADP)-ribose) polymerase inhibitor
06/05/2013CN102114430B Catalyst and preparation method thereof as well as method for preparing N-alkylpyrrole derivatives
06/05/2013CN102083832B Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 Tachikynin receptor antagonists
06/05/2013CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
06/05/2013CN101906096B 3,4-dihydropyridine-2-ketone heterocyclic compound and application thereof
06/05/2013CN101899043B Tylophora ovata base analogs with anti-tumor activity and preparation method and use thereof
06/05/2013CN101679363B Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
06/05/2013CN101570505B Indole-2, 3-diformic ester compound and derivatives and synthetic method
06/05/2013CN101433565B Total alkaloid extract of seeds of harmel genus, and preparation thereof
06/05/2013CN101193889B Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I
06/05/2013CN101133060B Enzyme inhibitors
06/04/2013US8455866 Heterocyclic compound and organic light-emitting device including the same
06/04/2013US8455653 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
06/04/2013US8455645 Pyrrolopyridine derivatives and their use as CRTH2 antagonists
06/04/2013US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group
06/04/2013US8455498 Inhibitors of histone deacetylase
06/04/2013US8455490 Facially amphiphilic polymers and oligomers and uses thereof
06/04/2013US8455486 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
06/04/2013US8455485 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
06/04/2013US8455484 Selected inhibitors of protein tyrosine kinase activity
06/04/2013CA2545660C Heterocyclic inhibitors of mek and methods of use thereof
06/04/2013CA2545659C Bicyclic inhibitors of mek
06/01/2013CA2760174A1 Protein kinase inhibitors and uses thereof
05/2013
05/30/2013WO2013078441A1 Heterocyclic compounds and uses thereof
05/30/2013WO2013078254A1 Bicyclic heteroaryl derivatives as kinase inhibitors
05/30/2013WO2013076168A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines
05/30/2013WO2013076092A1 Process for preparing n-substituted 1h-pyrazole-5-carboxylate compounds and derivatives thereof
05/30/2013WO2013075785A1 3-cyanaryl-1h-pyrazolo[2.3-b]pyridine derivatives
05/30/2013WO2013013068A4 Embodiments of a probe and method for targeting nucleic acids
05/30/2013US20130137705 Pyrido[3,4-b]indoles and methods of use
05/30/2013US20130137700 Fused heterocyclic ring compound
05/30/2013US20130137684 Haematopoietic-prostaglandin d2 synthase inhibitors
05/30/2013US20130137681 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
05/30/2013US20130137680 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
05/30/2013US20130137679 Novel Functionally Selective Ligands of Dopamine D2 Receptors
05/30/2013US20130137672 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
05/30/2013US20130137577 Oxopyrazine derivative and herbicide
05/30/2013US20130137574 Herbicidal compounds
05/30/2013CA2856706A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines
05/30/2013CA2856357A1 3-cyanoaryl-1h-pyrrolo[2,3-b]pyridine derivatives
05/29/2013EP2597095A1 Fused heterocyclic compound and application thereof
05/29/2013EP2597094A1 Imidazopyridine derivatives and organic electroluminescent elements containing same
05/29/2013EP2597088A1 P2x4 receptor antagonist
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 646